The Nurse Practitioner in the Primary Care setting is challenged in the treatment of ASCVD to provide the most up-to-date goals, treatment guidelines, and expectations for primary vs secondary prevention. This program will sift through the complicated updates of the past few years and allow the nurse practitioner to incorporate these into their practice. | 1.00 credits (1.00 pharmacology) | $30

Nurse Practitioners are on the front line in the role of treating adults with Type 2 Diabetes Mellitus. According to the CDC more than 34 million Americans have diabetes (about 1in 10), and approximately 90-95% of them have type 2 diabetes. Type 2 diabetes most often develops in people over age 45 but more and more often teens and young adults are also developing it. | 1.00 credits (1.00 pharmacology) | $30

Over the past 10 years, many of the options available to treat osteoarthritis and rheumatoid arthritis have come under scrutiny. Many products have been pulled from the market. Throughout this lecture, Ms. Wright will discuss the pathophysiology of osteoarthritis and rheumatoid arthritis. In addition, all pharmacologic therapies currently utilized for patients with both OA and RA will be discussed including their use, side effects, benefits, and drug-drug interactions. | 1.50 credits (1.50 pharmacology) | $45

Headaches are one of the most common diagnoses seen in the primary and urgent care setting. This presentation will discuss primary headache syndromes including migraines, cluster headaches, and tension-type headaches. The activity will give an overview of both evidence-based treatment therapies and alternate treatment options for migraines and other types of headaches. | 1.00 credits (1.00 pharmacology) | $30.00

The prescriber has numerous options for pharmacologic treatment of insomnia, including a variety of both controlled and non-controlled substances. This program reviews the physiology of sleep disorders as a basis for understanding why the different drug classes produces such different results from one patient to the next. Although non-pharmacologic strategies are an important part of managing sleep disorders, best use of pharmacologic options are an important tool in maximizing restorative sleep. | 1.5 credits (1.5 pharmacology) | $45

At least 116 million U.S. adults—more than the number affected by heart disease, diabetes, and cancer combined—suffer from common chronic pain conditions. Across the life span, pain—acute and chronic—is one of the most frequent reasons for clinician visits, among the most common reasons for taking medications, and a major cause of work disability. The over reliance on pharmacotherapies alone, in particular the use of chronic opioids, in recent years has been seen as a highly ineffective way of managing chronic pain. The HHS Pain Management Best Practices Inter-Agency Task Force in 2019 released a report for best practice in the management of chronic and acute pain, highlighting the use of a multimodal treatment strategy for improved outcomes. Healthcare Providers need the education, resources and tools to engage and effectively manage their patients with chronic pain. In this up-to-date review, we will discuss the most practical, evidenced based, possibly overlooked non-pharmacological modalities that clinicians can use either as standalone agents or in a combined multimodal treatment approach for the best possible outcomes in managing patients with chronic pain conditions. | 1.0 credits (0 pharmacology) | $27.50

Using a case-based approach, this session will highlight new and innovative management options for patients with chronic kidney disease, particularly focusing on new therapeutics in the management of diabetic nephropathy. | 1.5 credits (0.50 pharmacology) | $37.50

Since primary care providers manage approximately 90% of COPD cases, it stands to reason that COPD guidelines should be tailored to a primary care perspective. This session will be a comprehensive update including a review of clinical assessment, therapeutics and case management of patients with COPD. We will review current 2021 GOLD guidelines and discuss the management of COPD during the COVID19 pandemic. This session will include updates in current COPD research that are relevant to practical management of COPD patients in outpatient clinic using case examples. | 1.50 credits (1.50 pharmacology) | $37.50

This session will cover neurotransmitters that are targeted for treating depression and anxiety. Learn to recognize symptoms and severity of depression and anxiety disorders as listed in DSM IV and their influence on ADL. Also, get a better understanding of medication side effects, adverse events, and the barriers for adherence for patients to achieve remission of their symptoms. | 1.50 credits (1.50 pharmacology) | $40.00

This presentation will review the 2020 CDC STI Treatment Guidelines focusing on important changes since 2015, including new screening recommendations, new treatment regimens and new prevention messages. | 1.50 credits (1.50 pharmacology) | $40.00